These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

264 related items for PubMed ID: 22532871

  • 1. Disruption of a GATA4/Ankrd1 signaling axis in cardiomyocytes leads to sarcomere disarray: implications for anthracycline cardiomyopathy.
    Chen B, Zhong L, Roush SF, Pentassuglia L, Peng X, Samaras S, Davidson JM, Sawyer DB, Lim CC.
    PLoS One; 2012; 7(4):e35743. PubMed ID: 22532871
    [Abstract] [Full Text] [Related]

  • 2. Cardiac ankyrin repeat protein attenuates cardiomyocyte apoptosis by upregulation of Bcl-2 expression.
    Zhang N, Ye F, Zhu W, Hu D, Xiao C, Nan J, Su S, Wang Y, Liu M, Gao K, Hu X, Chen J, Yu H, Xie X, Wang J.
    Biochim Biophys Acta; 2016 Dec; 1863(12):3040-3049. PubMed ID: 27713078
    [Abstract] [Full Text] [Related]

  • 3. Targeted inhibition of ANKRD1 disrupts sarcomeric ERK-GATA4 signal transduction and abrogates phenylephrine-induced cardiomyocyte hypertrophy.
    Zhong L, Chiusa M, Cadar AG, Lin A, Samaras S, Davidson JM, Lim CC.
    Cardiovasc Res; 2015 May 01; 106(2):261-71. PubMed ID: 25770146
    [Abstract] [Full Text] [Related]

  • 4. A novel cardiac-restricted target for doxorubicin. CARP, a nuclear modulator of gene expression in cardiac progenitor cells and cardiomyocytes.
    Jeyaseelan R, Poizat C, Baker RK, Abdishoo S, Isterabadi LB, Lyons GE, Kedes L.
    J Biol Chem; 1997 Sep 05; 272(36):22800-8. PubMed ID: 9278441
    [Abstract] [Full Text] [Related]

  • 5. A novel role for cardiac ankyrin repeat protein Ankrd1/CARP as a co-activator of the p53 tumor suppressor protein.
    Kojic S, Nestorovic A, Rakicevic L, Belgrano A, Stankovic M, Divac A, Faulkner G.
    Arch Biochem Biophys; 2010 Oct 01; 502(1):60-7. PubMed ID: 20599664
    [Abstract] [Full Text] [Related]

  • 6. Transcription factor GATA4 inhibits doxorubicin-induced autophagy and cardiomyocyte death.
    Kobayashi S, Volden P, Timm D, Mao K, Xu X, Liang Q.
    J Biol Chem; 2010 Jan 01; 285(1):793-804. PubMed ID: 19901028
    [Abstract] [Full Text] [Related]

  • 7. Alpha(1)-adrenergic activation of the cardiac ankyrin repeat protein gene in cardiac myocytes.
    Maeda T, Sepulveda J, Chen HH, Stewart AF.
    Gene; 2002 Sep 04; 297(1-2):1-9. PubMed ID: 12384280
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Transcription factor gata4 regulates cardiac BCL2 gene expression in vitro and in vivo.
    Kobayashi S, Lackey T, Huang Y, Bisping E, Pu WT, Boxer LM, Liang Q.
    FASEB J; 2006 Apr 04; 20(6):800-2. PubMed ID: 16469847
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. GATA4-targeted compound exhibits cardioprotective actions against doxorubicin-induced toxicity in vitro and in vivo: establishment of a chronic cardiotoxicity model using human iPSC-derived cardiomyocytes.
    Karhu ST, Kinnunen SM, Tölli M, Välimäki MJ, Szabó Z, Talman V, Ruskoaho H.
    Arch Toxicol; 2020 Jun 04; 94(6):2113-2130. PubMed ID: 32185414
    [Abstract] [Full Text] [Related]

  • 13. MiR-15b-5p is Involved in Doxorubicin-Induced Cardiotoxicity via Inhibiting Bmpr1a Signal in H9c2 Cardiomyocyte.
    Wan GX, Cheng L, Qin HL, Zhang YZ, Wang LY, Zhang YG.
    Cardiovasc Toxicol; 2019 Jun 04; 19(3):264-275. PubMed ID: 30535663
    [Abstract] [Full Text] [Related]

  • 14. Myocardial overexpression of ANKRD1 causes sinus venosus defects and progressive diastolic dysfunction.
    Piroddi N, Pesce P, Scellini B, Manzini S, Ganzetti GS, Badi I, Menegollo M, Cora V, Tiso S, Cinquetti R, Monti L, Chiesa G, Bleyl SB, Busnelli M, Dellera F, Bruno D, Caicci F, Grimaldi A, Taramelli R, Manni L, Sacerdoti D, Tesi C, Poggesi C, Ausoni S, Acquati F, Campione M.
    Cardiovasc Res; 2020 Jul 01; 116(8):1458-1472. PubMed ID: 31688894
    [Abstract] [Full Text] [Related]

  • 15. 26S proteasome regulation of Ankrd1/CARP in adult rat ventricular myocytes and human microvascular endothelial cells.
    Samaras SE, Chen B, Koch SR, Sawyer DB, Lim CC, Davidson JM.
    Biochem Biophys Res Commun; 2012 Sep 07; 425(4):830-5. PubMed ID: 22892129
    [Abstract] [Full Text] [Related]

  • 16. Gata4 and Sp1 regulate expression of the erythropoietin receptor in cardiomyocytes.
    Salisch Sv, Klar M, Thurisch B, Bungert J, Dame C.
    J Cell Mol Med; 2011 Sep 07; 15(9):1963-72. PubMed ID: 21029371
    [Abstract] [Full Text] [Related]

  • 17. Impact of ANKRD1 mutations associated with hypertrophic cardiomyopathy on contraction parameters of engineered heart tissue.
    Crocini C, Arimura T, Reischmann S, Eder A, Braren I, Hansen A, Eschenhagen T, Kimura A, Carrier L.
    Basic Res Cardiol; 2013 May 07; 108(3):349. PubMed ID: 23572067
    [Abstract] [Full Text] [Related]

  • 18. Mechanism of anthracycline-mediated down-regulation of GATA4 in the heart.
    Park AM, Nagase H, Liu L, Vinod Kumar S, Szwergold N, Wong CM, Suzuki YJ.
    Cardiovasc Res; 2011 Apr 01; 90(1):97-104. PubMed ID: 21084315
    [Abstract] [Full Text] [Related]

  • 19. Preventive effect of erythropoietin on cardiac dysfunction in doxorubicin-induced cardiomyopathy.
    Li L, Takemura G, Li Y, Miyata S, Esaki M, Okada H, Kanamori H, Khai NC, Maruyama R, Ogino A, Minatoguchi S, Fujiwara T, Fujiwara H.
    Circulation; 2006 Jan 31; 113(4):535-43. PubMed ID: 16449733
    [Abstract] [Full Text] [Related]

  • 20. The Abl1 tyrosine kinase is a key player in doxorubicin-induced cardiomyopathy and its p53/p73 cell death mediated signaling differs in atrial and ventricular cardiomyocytes.
    Borlak J, Ciribilli Y, Bisio A, Selvaraj S, Inga A, Oh JH, Spanel R.
    J Transl Med; 2024 Sep 16; 22(1):845. PubMed ID: 39285385
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.